| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/21/2008 | WO2007136746A3 Macrocyclic compounds and their uses as stearoyl-coa desaturase |
| 02/21/2008 | WO2007130860A3 Constrained compounds as cgrp-receptor antagonists |
| 02/21/2008 | WO2007087068A3 Inhibitors of tyrosine kinases and uses thereof |
| 02/21/2008 | WO2007075809A3 Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| 02/21/2008 | US20080045713 Tetrahydroisoquinolinedione derivative intermediates for the hemisynthesis of ecteinascidin or other tetrahydroisoquinolinephenol compounds |
| 02/21/2008 | US20080045709 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/21/2008 | US20080045581 Ppar active compounds |
| 02/21/2008 | US20080045563 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation |
| 02/21/2008 | US20080045562 Substituted Thieno[3,2-C]Pyridine-7-Carboxylic Acid Derivatives |
| 02/21/2008 | US20080045561 protein kinase inhibitors such as 5,6-Dimethoxy-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-pyrrolo[3,2-b]pyridine, used for the treatment of cancer |
| 02/21/2008 | US20080045559 Tocopherol-modified therapeutic drug compounds |
| 02/21/2008 | US20080045538 Nitro and amino substituted topoisomerase agents |
| 02/21/2008 | US20080045511 3-chloro-5-[6-chloro-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)-phenoxy]-benzonitrile; inhibit HIV reverse transcriptase and are useful for treating Human Immunodeficiency Virus (HIV) mediated diseases |
| 02/21/2008 | US20080045501 Pyrido(Hetero or carbo)cyclo)azepinylamine derivatives, e.g., 4-{[9-chloro-7-(2,6-difluorophenyl)-5H-pyrido[3,4-d][2]benzazepin-2-yl]amino}-benzoic acid; 3-{[9-chloro-7-(2,6-difluorophenyl)-5H-pyrido[3,2-d][2]benzazepin-2-yl]-amino}benzoic acid; Aurora kinase inhibitors; anticancer agents |
| 02/21/2008 | US20080045498 Polycyclic viral inhibitors |
| 02/21/2008 | CA2660441A1 Imidazole amines as inhibitors of .beta.-secretase |
| 02/21/2008 | CA2659276A1 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 02/21/2008 | CA2658984A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/21/2008 | CA2658960A1 Phenyl, pyridine and quinoline derivatives |
| 02/21/2008 | CA2650932A1 Substituted spirocyclic cgrp receptor antagonists |
| 02/20/2008 | EP1888585A1 Tetracyclic azapyrazinoindolines as 5-ht2 ligands |
| 02/20/2008 | EP1888584A1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity |
| 02/20/2008 | EP1888583A2 Hydantoin compounds |
| 02/20/2008 | EP1888582A1 Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 02/20/2008 | EP1888581A2 Hiv-integrase inhibitor compounds |
| 02/20/2008 | EP1888580A2 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof |
| 02/20/2008 | EP1888579A2 Novel fluorene derivatives, composition containing said derivatives and the use thereof |
| 02/20/2008 | EP1888578A2 Imidazoquinolines as lipid kinase inhibitors |
| 02/20/2008 | EP1888577A1 Ocaperidone salts and pharmaceutical compositions containing the same |
| 02/20/2008 | EP1888534A2 Organic compounds |
| 02/20/2008 | EP1888530A2 Quinoline derivatives as neurokinin receptor antagonists |
| 02/20/2008 | EP1556381B1 Pyrazole amides for treating hiv infections |
| 02/20/2008 | EP1448561B1 Beta 3 adrenergic agonists |
| 02/20/2008 | EP1432417B1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 02/20/2008 | EP1404704B9 Bridged bicyclic serine protease inhibitors |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1127059B1 Imidazonaphthyridines |
| 02/20/2008 | EP0938315B9 Immune response modifier compounds for treatment of th2 mediated and related diseases |
| 02/20/2008 | CN101128464A Process of synthesizing tadalafil |
| 02/20/2008 | CN101128463A Process of purifying tadalafil |
| 02/20/2008 | CN101128462A Preparation of high purity substituted quinoxaline |
| 02/20/2008 | CN101128461A Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors |
| 02/20/2008 | CN101128204A 2,4-diamino-pyridopyrimidine derivatives and their use as mTOR inhibitors |
| 02/20/2008 | CN101125138A Inhibitors against the production and release of inflammatory cytokines |
| 02/20/2008 | CN100369912C Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 02/20/2008 | CN100369899C Substituted indazoles with anti-cancer activity |
| 02/20/2008 | CN100369896C Cyclic amino compounds |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/19/2008 | US7332519 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene |
| 02/19/2008 | US7332509 Used for controlling animal pests, in particular arthropods, such as insects and acarids, and helminths |
| 02/19/2008 | US7332506 Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression |
| 02/19/2008 | US7332505 Gastrointestinal disorders; facilitating healing and decreasing recurrence of ulcers; low dosage, reduced side effects |
| 02/19/2008 | US7332502 Phenanthroindolizidine alkaloids |
| 02/19/2008 | US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 02/19/2008 | US7332494 Method for treating allergies using substituted pyrazoles |
| 02/19/2008 | US7332492 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor |
| 02/19/2008 | US7332491 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease |
| 02/19/2008 | US7332488 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332487 Nitrogen-containing 5-membered ring compound |
| 02/19/2008 | CA2312167C Process for the continuous preparation of quinacridones |
| 02/14/2008 | WO2008019309A1 Novel inhibitors of fructose 1,6-bisphosphatase |
| 02/14/2008 | WO2008017461A1 1, 7-naphthyridine derivatives as p38 map kinase inhibitors |
| 02/14/2008 | WO2007146250A3 Naphthalene-based semiconductor materials and methods of preparing and use thereof |
| 02/14/2008 | WO2007146124A3 Deuterated tadalafil derivatives |
| 02/14/2008 | WO2007117486A3 Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl] -8-phenyl-1,7-diaza-spiro[4.5] decan-2-one and preparation process therefor |
| 02/14/2008 | WO2007117381A3 2 -aminopyridine analogs as glucokinase activators |
| 02/14/2008 | US20080039630 Cyanine compounds and their application as quenching compounds |
| 02/14/2008 | US20080039491 Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use |
| 02/14/2008 | US20080039490 Pyridines for treating injured mammalian nerve tissue |
| 02/14/2008 | US20080039489 Tetrahydrofuran derivatives for use as inhibitors of matrix metalloproteinases |
| 02/14/2008 | US20080039488 Salt of naphthyridine carboxylic acid derivative |
| 02/14/2008 | US20080039487 Processes and intermediates useful for preparing integrase inhibitor compounds |
| 02/14/2008 | US20080039479 Compounds and therapeutical use thereof |
| 02/14/2008 | US20080039469 3-Benzyl-3a-cyclobutyl-7-methoxymethyl-2-oxo-octahydro-oxazolo[4,5-c]pyridin-5-ium; useful as agents for stimulating the cognitive functions of the brain |
| 02/14/2008 | US20080039466 2-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase Inhibitors |
| 02/14/2008 | US20080039462 Compounds having 5-HT6 receptor affinity |
| 02/14/2008 | US20080039452 Fused Quinoline Derivative and Use Thereof |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080036373 Platinum complex and light-emitting device |
| 02/14/2008 | US20080035914 Use of perylene diimide derivatives as air-stable n-channel organic semiconductors |
| 02/14/2008 | US20080035885 Prmitting its use in medium such as an aqueous medium that is devoid of peroxygen bleach or a peroxy-based or -generating bleach system; Dimethyl 2,4-di-(2-pyridyl) -3-methyl-7-(pyridin-2-ylmethyl)-3,7-diaza-bicyclo[3.3.1]nonan-9-one-1,5-dicarboxylate (N2py3o-C1) and the iron complex; laundering |
| 02/13/2008 | EP1887007A2 Novel compounds |
| 02/13/2008 | EP1887002A1 Carboxamide compound and use thereof |
| 02/13/2008 | EP1886999A2 Bicyclic heteroaromatic compound |
| 02/13/2008 | EP1886994A1 Cyclic amine compounds as CCR5 antagonists |
| 02/13/2008 | EP1885724A1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 02/13/2008 | EP1885723A2 Pyrrolo[2,3-b]pyridine derivatives as protein kinase inhibitors |
| 02/13/2008 | EP1885722A1 Quinoline derivatives as ep4 antagonists |
| 02/13/2008 | EP1885721A2 Metal chelates of polyaminocarboxylic macrocyclic derivatives and use thereof in diagnostic imaging |
| 02/13/2008 | EP1885713A1 1, 2, 4 -triazole derivatives as vasopressin antagonists |
| 02/13/2008 | EP1885369A2 Fused heterocyclic compounds, and compositions and uses thereof |
| 02/13/2008 | EP1885359A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors |
| 02/13/2008 | EP1680421B1 Use of tricyclic compounds as glycine transport inhibitors |
| 02/13/2008 | EP1678175B1 Medical use of zwitterionic compounds being cftr channel modulators |
| 02/13/2008 | EP1644371B1 Pyrazoloisoquinoline derivatives as kinase inhibitors |
| 02/13/2008 | EP1641793B1 Novel imidazopyridine compound ii with therapeutic effect |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1414820B1 Non-nucleoside reverse transcriptase inhibitors |
| 02/13/2008 | EP1044189B1 Aryl fused azapolycyclic compounds |
| 02/13/2008 | CN101124229A Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |